Literature DB >> 18424581

Importance of checking anti-glomerular basement membrane antibody status in patients with anti-neutrophil cytoplasmic antibody-positive vasculitis.

J L Gallagher1, S Sinha, R Reeve, P A Kalra.   

Abstract

The case is reported of a 68-year-old man with perinuclear anti-neutrophil cytoplasmic antibody (pANCA)-associated glomerulonephritis who developed antibodies to glomerular basement membrane (anti-GBM) resulting in end stage renal failure. His pANCA titre on admission was 1:1024 IgG and he was anti-myeloperoxidase positive. A renal biopsy showed advanced sclerosing necrotising glomerulonephritis consistent with a pauci-immune ANCA-positive glomerulonephritis. He was treated with steroids and cyclophosphamide. His serum creatinine profile improved. He had a relapse of disease 16 months later, which was successfully treated. After a further 16 months, he presented with acute renal failure (creatinine 1060 micromol/l). His pANCA titre on admission was 1:64 IgG. This was treated as a further relapse of ANCA-positive vasculitis. He became oliguric and his haemoglobin concentration fell. Eight days after admission, he was found to be strongly positive for anti-GBM (138 U/ml). Despite receiving cyclophosphamide, steroids and plasma exchange, he remained dialysis-dependent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424581     DOI: 10.1136/pgmj.2007.062752

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  2 in total

1.  A relapsing case of pulmonary-renal syndrome after a sequential rise in MPO-ANCA and anti-GBM antibodies.

Authors:  Akiko Hoshino; Toru Sakairi; Ken Kayakabe; Masahito Baba; Masayasu Ando; Hayato Kimura; Rena Motohashi; Yoshihisa Nojima; Keiju Hiromura
Journal:  CEN Case Rep       Date:  2019-04-03

2.  Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease.

Authors:  Stephen W Olson; Charles B Arbogast; Thomas P Baker; David Owshalimpur; David K Oliver; Kevin C Abbott; Christina M Yuan
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.